<VariationArchive VariationID="372246" VariationName="NM_020810.3(TRMT5):c.312_315del (p.Ile105fs)" VariationType="Deletion" Accession="VCV000372246" Version="62" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-15" DateCreated="2017-11-05" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="359151" VariationID="372246">
      <GeneList>
        <Gene Symbol="TRMT5" FullName="tRNA methyltransferase 5" GeneID="57570" HGNC_ID="HGNC:23141" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="60971441" stop="60981690" display_start="60971441" display_stop="60981690" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="61438158" stop="61447781" display_start="61438158" display_stop="61447781" Strand="-" />
          </Location>
          <OMIM>611023</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020810.3(TRMT5):c.312_315del (p.Ile105fs)</Name>
      <CanonicalSPDI>NC_000014.9:60979582:TATTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="60979583" stop="60979586" display_start="60979583" display_stop="60979586" variantLength="4" positionVCF="60979582" referenceAlleleVCF="CTATT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="61446301" stop="61446304" display_start="61446301" display_stop="61446304" variantLength="4" positionVCF="61446300" referenceAlleleVCF="CTATT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>I105fs</ProteinChange>
      <ProteinChange>I132fs</ProteinChange>
      <ProteinChange>I133fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.61446302_61446305del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.61446302_61446305del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.60979584_60979587del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.60979584_60979587del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053119.1" sequenceAccession="NG_053119" sequenceVersion="1" change="g.7105_7108del">
            <Expression>NG_053119.1:g.7105_7108del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350253.1" sequenceAccession="NM_001350253" sequenceVersion="1" change="c.396_399del">
            <Expression>NM_001350253.1:c.396_399del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001337182.1" sequenceAccession="NP_001337182" sequenceVersion="1" change="p.Ile133fs">
            <Expression>NP_001337182.1:p.Ile133fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350254.1" sequenceAccession="NM_001350254" sequenceVersion="1" change="c.393_396del">
            <Expression>NM_001350254.1:c.393_396del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001337183.1" sequenceAccession="NP_001337183" sequenceVersion="1" change="p.Ile132fs">
            <Expression>NP_001337183.1:p.Ile132fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020810.3" sequenceAccession="NM_020810" sequenceVersion="3" change="c.312_315del" MANESelect="true">
            <Expression>NM_020810.3:c.312_315del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065861.3" sequenceAccession="NP_065861" sequenceVersion="3" change="p.Ile105fs">
            <Expression>NP_065861.3:p.Ile105fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020810.3" sequenceAccession="NM_020810" sequenceVersion="3" change="c.312_315delAATA" MANESelect="true">
            <Expression>NM_020810.3:c.312_315delAATA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7213943" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611023.0001" DB="OMIM" />
        <XRef Type="rs" ID="755184077" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020810.3(TRMT5):c.312_315del (p.Ile105fs) AND Combined oxidative phosphorylation defect type 26" Accession="RCV000412579" Version="16">
        <ClassifiedConditionList TraitSetID="22470">
          <ClassifiedCondition DB="MedGen" ID="C5567741">Combined oxidative phosphorylation defect type 26</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-04-27" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020810.3(TRMT5):c.312_315del (p.Ile105fs) AND not provided" Accession="RCV000513771" Version="33">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2023-09-14" SubmissionCount="4">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020810.3(TRMT5):c.312_315del (p.Ile105fs) AND not specified" Accession="RCV004525925" Version="4">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-01" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-01" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2017-11-05" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(2); Likely pathogenic(1); Uncertain significance(3)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">2544623</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26189817</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29021354</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31038196</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35342985</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(2); Likely pathogenic(1); Uncertain significance(3)</Comment>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-12-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="22470" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34133" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY</ElementValue>
                <XRef Type="MIM" ID="616539" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611023.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611023.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611023.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611023.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Combined oxidative phosphorylation defect type 26</ElementValue>
                <XRef ID="MONDO:0014684" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Combined oxidative phosphorylation deficiency 26</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PNSED</ElementValue>
                <XRef Type="MIM" ID="616539" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17854" />
                <XRef ID="17854" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef Type="MIM" ID="616539" DB="OMIM" />
              <XRef ID="477684" DB="Orphanet" />
              <XRef ID="C5567741" DB="MedGen" />
              <XRef ID="MONDO:0014684" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="957595" SubmissionDate="2022-06-01" DateLastUpdated="2022-06-05" DateCreated="2017-01-07">
        <ClinVarSubmissionID localKey="611023.0001_PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY" title="TRMT5, 4-BP DEL, NT312 (rs755184077)_PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY" />
        <ClinVarAccession Accession="SCV000490321" DateUpdated="2022-06-05" DateCreated="2017-01-07" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 unrelated patients (patient 73901, previously reported by Haller et al. (1989), and patient 65205), with peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay (PNSED; 616539), Powell et al. (2015) identified compound heterozygous mutations in the TRMT5 gene. Both patients carried a 4-bp deletion (c.312_315del, NM_020810.3), resulting in a frameshift and premature termination (Ile105SerfsTer4) on 1 allele, and a different pathogenic mutation on the second allele: a c.872G-A transition, resulting in an arg291-to-his (R291H; 611023.0002) and a c.1156A-G transition, resulting in a met386-to-val (M386V; 611023.0003) substitution, respectively. Both missense mutations occurred at highly conserved residues. The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated within the families according to DNA available from family members. None of the variants were present in an in-house exome database of over 5,700 samples. In the ExAC database, c.312_315del and c.872G-A were found at low frequencies (0.0009 and 0.00004, respectively). The Ile105SerfsTer4 mutation is predicted to truncate the protein upstream of the methyltransferase motif and thus be nonfunctional. A reverse-transcription primer extension (RT-PEx) assay performed on patient-derived fibroblasts and skeletal muscle tissue indicated that mt-tRNA(Leu-CUN) had decreased G37 modification compared to controls, with a more significant effect in the patient with the more severe phenotype. Downregulation of TRMT5 in HeLa cells resulted in a similar effect. In addition, neither missense mutation was able to rescue defective mitochondrial respiratory activity in a yeast knockout model, consistent with a loss of function.</Attribute>
              <Citation>
                <ID Source="PubMed">2544623</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">26189817</ID>
              </Citation>
              <XRef DB="OMIM" ID="616539" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sisters with PNSED, Tarnopolsky et al. (2017) identified compound heterozygosity for 2 mutations in the TRMT5 gene: c.312_315del and R291H (611023.0002). The mutations, which were found by whole-exome sequencing, occurred in trans. Functional studies of the variants and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">29021354</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated patients of Southern European descent with PNSED, Argente-Escrig et al. (2022) identified compound heterozygosity for c.312_315del and a c.665T-C transition, resulting in an ile222-to-thr (I222T) substitution at a highly conserved residue in the D2 domain (611023.0004). The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in all families. I222T was present once in the heterozygous state in the gnomAD database (1 of 241,828 alleles), whereas c.312_315del was found in the heterozygous state in 246 of 282,782 alleles. Functional studies of the variants and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">35342985</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRMT5" />
          </GeneList>
          <Name>TRMT5, 4-BP DEL, NT312 (rs755184077)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, NT312 (rs755184077)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611023.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1190769" SubmissionDate="2017-10-05" DateLastUpdated="2017-11-05" DateCreated="2017-11-05">
        <ClinVarSubmissionID localKey="30881556" />
        <ClinVarAccession Accession="SCV000610714" DateUpdated="2017-11-05" DateCreated="2017-11-05" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.001117</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" Strand="+" alternateAllele="-" referenceAllele="TATT" start="61446301" stop="61446304" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2021894" SubmissionDate="2023-01-10" DateLastUpdated="2023-02-07" DateCreated="2019-12-17">
        <ClinVarSubmissionID localKey="2917908|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001053996" DateUpdated="2023-02-07" DateCreated="2019-12-17" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26189817</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29021354</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile105Serfs*4) in the TRMT5 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in TRMT5 cause disease. This variant is present in population databases (rs755184077, gnomAD 0.3%), and has an allele count higher than expected for a pathogenic variant. This premature translational stop signal has been observed in individual(s) with features of combined oxidative phosphorylation deficiency (PMID: 26189817, 29021354). ClinVar contains an entry for this variant (Variation ID: 372246). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRMT5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.61446301_61446304del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7329850" SubmissionDate="2023-04-28" DateLastUpdated="2023-11-04" DateCreated="2023-11-04">
        <ClinVarSubmissionID localKey="NM_020810.3:c.312_315del|OMIM:616539" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003920742" DateUpdated="2023-11-04" DateCreated="2023-11-04" Type="SCV" Version="1" SubmitterName="Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL)" OrgID="509068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRMT5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020810.3:c.312_315del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616539" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13188883</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7554425" SubmissionDate="2023-09-27" DateLastUpdated="2023-09-30" DateCreated="2023-09-30">
        <ClinVarSubmissionID localKey="GDXSV:289669" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004036831" DateUpdated="2023-09-30" DateCreated="2023-09-30" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; This variant is associated with the following publications: (PMID: 34426522, 31038196, 26189817, 29021354, 35342985)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRMT5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1749980</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020810.3:c.312_315del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_221_20230927054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4908464" SubmissionDate="2024-06-28" DateLastUpdated="2024-06-29" DateCreated="2022-05-16">
        <ClinVarSubmissionID localKey="NM_020810.3:c.312_315delAATA|MedGen:CN169374" />
        <ClinVarAccession Accession="SCV002511860" DateUpdated="2024-06-29" DateCreated="2022-05-16" Type="SCV" Version="5" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31038196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26189817</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29021354</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35342985</ID>
          </Citation>
          <Comment>Variant summary: TRMT5 c.312_315delAATA (p.Ile105SerfsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The tRNA methyltransferase 5 (TRMT5) gene encodes a protein involved in methylation of a specific nucleotide (position 37) adjacent to the anticodon of mitochondrial-tRNA molecules to enhance their translational efficiency/fidelity (Tarnopolsky_2017). The p.Ile105Serfs*4 frameshift mutation is upstream of the methyltransferase motif, therefore it is predicted to result in a truncated protein that is expected to be non-functional (Powell_2015). The variant allele was found at a frequency of 0.00087 in 251378 control chromosomes, predominantly at a frequency of 0.0013 within the Non-Finnish European subpopulation in the gnomAD database. As the prevalence of Combined Oxidative Phosphorylation Defect Type 26 and attributable risk of TRMT5 gene and variants cannot be estimated, this frequency does not allow conclusions about variant significance. c.312_315delAATA has been reported in the literature as a compound heterozygous genotype with other TRMT5 missense variants in trans in at least seven probands from six separate families presenting with varying clinical features, suggestive of mitochondrial disease (e.g., Powell_2015, Tarnopolsky_2017, Argente-Escrig_2022). Each of these probands were comprehensively evaluated to rule out other genetic conditions prior to whole exome sequencing (WES). It has also been reported as a non-informative genotype (zygosity/genotype not specified) in an autistic proband who underwent whole genome sequencing (e.g., Callaghan_2019) but has not been considered as a relevant correlation in the context of this evaluation. These data indicate that the variant might be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 372246). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRMT5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020810.3:c.312_315delAATA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN169374" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11463985</SubmissionName>
          <SubmissionName>clinvar-submission.2024-03.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2468482" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-09">
        <ClinVarSubmissionID localKey="100452|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001246883" DateUpdated="2024-07-15" DateCreated="2020-05-09" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>TRMT5: PS4, PM4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TRMT5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="14" alternateAllele="C" referenceAllele="CTATT" start="61446300" stop="61446304" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7329850" TraitType="Disease" MappingType="XRef" MappingValue="616539" MappingRef="OMIM">
        <MedGen CUI="C5567741" Name="Combined oxidative phosphorylation defect type 26" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="957595" TraitType="Disease" MappingType="Name" MappingValue="PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY" MappingRef="Preferred">
        <MedGen CUI="C5567741" Name="Combined oxidative phosphorylation defect type 26" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1190769" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7554425" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2021894" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2468482" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4908464" TraitType="Disease" MappingType="XRef" MappingValue="CN169374" MappingRef="MedGen">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001528121</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

